Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.27B |
| 2 |
QXO
QXO Inc
QXO
|
+$1.14B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.06B |
| 4 |
Thermo Fisher Scientific
TMO
|
+$505M |
| 5 |
Walt Disney
DIS
|
+$502M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$1.46B |
| 2 |
NVIDIA
NVDA
|
+$938M |
| 3 |
Microsoft
MSFT
|
+$734M |
| 4 |
McDonald's
MCD
|
+$609M |
| 5 |
Chipotle Mexican Grill
CMG
|
+$544M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.37% |
| 2 | Healthcare | 3.33% |
| 3 | Consumer Discretionary | 2.43% |
| 4 | Financials | 2.27% |
| 5 | Industrials | 1.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
OMGA
5101
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
| $2.14M | ﹤0.01% |
1,033,135
+1,009,635
| +4,296% | +$2.38M |
|
5102
Intapp
INTA
$3.01B
| $2.14M | ﹤0.01% |
58,272
+58,264
| +728,300% | +$1.98M |
|
5103
Encore Capital Group
ECPG
$2.23B
| $2.14M | ﹤0.01% |
51,182
-8,783
| -15% | -$379K |
|
5104
Cirrus Logic
CRUS
$6.06B
| $2.13M | ﹤0.01% |
16,714
-55,844
| -77% | -$5.86M |
|
5105
CALL
MidCap Financial Investment
MFIC
$798M
| $2.13M | ﹤0.01% |
140,900
-156,500
| -53% | -$2.4M |
|
5106
CALL
ImmunityBio
IBRX
$8.09B
| $2.13M | ﹤0.01% |
337,500
-105,900
| -24% | -$698K |
|
5107
iShares MSCI Emerging Markets ex China ETF
EMXC
$25.1B
| $2.13M | ﹤0.01% |
36,027
-10,098
| -22% | -$582K |
|
|
TBCH
5108
PUT
Turtle Beach Corp
TBCH
$224M
| $2.13M | ﹤0.01% |
148,700
-185,200
| -55% | -$2.88M |
|
5109
Navitas Semiconductor
NVTS
$3.74B
| $2.13M | ﹤0.01% |
542,532
+107,688
| +25% | +$453K |
|
5110
CALL
TPG
TPG
$8.47B
| $2.13M | ﹤0.01% |
51,400
+25,600
| +99% | +$1.1M |
|
5111
Skye Bioscience
SKYE
$19.5M
| $2.13M | ﹤0.01% |
+265,587
| New | +$3.15M |
|
5112
CALL
SiTime
SITM
$22.4B
| $2.13M | ﹤0.01% |
17,100
+400
| +2% | +$42.6K |
|
5113
First Trust Consumer Staples AlphaDEX Fund
FXG
$232M
| $2.12M | ﹤0.01% |
32,944
+18,433
| +127% | +$1.22M |
|
5114
WisdomTree International Multifactor Fund
DWMF
$34.4M
| $2.12M | ﹤0.01% |
81,065
+39,528
| +95% | +$1.05M |
|
5115
Genesco
GCO
$385M
| $2.12M | ﹤0.01% |
81,907
+52,107
| +175% | +$1.36M |
|
5116
Piper Sandler
PIPR
$5.35B
| $2.12M | ﹤0.01% |
36,768
-151,952
| -81% | -$7.79M |
|
5117
Provident Financial Services
PFS
$3.22B
| $2.12M | ﹤0.01% |
147,396
+49,821
| +51% | +$724K |
|
5118
Valaris
VAL
$5.98B
| $2.11M | ﹤0.01% |
28,384
-47,388
| -63% | -$3.43M |
|
|
TGNA
5119
CALL
DELISTED
TEGNA Inc
TGNA
| $2.11M | ﹤0.01% |
151,600
-13,400
| -8% | -$189K |
|
5120
indie Semiconductor
INDI
$999M
| $2.11M | ﹤0.01% |
+342,510
| New | +$2.18M |
|
5121
CALL
Avnet
AVT
$7.99B
| $2.11M | ﹤0.01% |
41,000
+22,700
| +124% | +$1.16M |
|
5122
PUT
Regal Rexnord
RRX
$11.6B
| $2.11M | ﹤0.01% |
15,600
-46,600
| -75% | -$7.25M |
|
5123
CALL
Henry Schein
HSIC
$10B
| $2.11M | ﹤0.01% |
32,900
-22,000
| -40% | -$1.55M |
|
5124
CALL
NeoGenomics
NEO
$2.04B
| $2.11M | ﹤0.01% |
152,000
+40,300
| +36% | +$571K |
|
5125
Payoneer
PAYO
$2.42B
| $2.11M | ﹤0.01% |
380,093
+86,551
| +29% | +$468K |
|
Similar funds
Ken Griffin's Q2 2024 Portfolio in Review
As of Q2 2024, Ken Griffin held 15,899 positions worth $494B, down 4.7% from $518B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Ken Griffin withdrew a net $42.4B in Q2 2024, closing 1,759 positions and reducing 6,731 holdings. Its most notable exit was Pioneer Natural Resource Co., an estimated $1.46B position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.4% of assets, down from 3.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Ken Griffin opened a new position in Carrier Global worth $140M.
- Ken Griffin's largest Q2 2024 buy was Carrier Global: 2,220,323 shares worth $140M.
- Ken Griffin added most to Invesco QQQ Trust in Q2 2024, an estimated $1.27B increase.
- Ken Griffin's biggest Q2 2024 reduction was NVIDIA, cutting an estimated $938M.
- Ken Griffin fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $1.46B.
- Ken Griffin's ten largest holdings make up 29% of its $494B portfolio in Q2 2024.
- Ken Griffin opened 1,434 new positions and closed 1,759 in Q2 2024.
- Ken Griffin's portfolio value fell 4.7% quarter-over-quarter to $494B.
Based on Citadel Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.